Labels over-the-counter use of electrocardiograph software devices as Class II (special controls), which requires manufactures to conduct hazard analysis of detection algorithms in the devices.
Labels over-the-counter use of electrocardiograph software devices as Class II (special controls), which requires manufactures to verify, validate, and conduct hazard analysis of detection algorithms in the devices.
Mandates manufactures to produce clinical performance testing results that shows the performance characteristics of the detection algorithm by sensitivity and either specificity or positive predictive value.
Requires manufacturers who fail to conduct non-clinical performance testing to validate detection algorithm performance using a previously adjudicated data set.
Requires human factors and usability testing to demonstrate that the user can correctly interpret the device output and understand when to seek medical care.
Key facts
🏛️ This document has been enacted by the U.S. Food and Drug Administration.
For authoritative text and metadata, visit the official source.
🎯 This document primarily applies to the private sector, rather than the government.
📜 This document's name is 21 CFR § 870.2345 ("Electrocardiograph software for over-the-counter use").
Themes AI risks, applications, governance strategies, and other themes addressed in AGORA documents.
This is an unofficial copy. The document has been
archived and reformatted in plaintext for AGORA. Footnotes, tables, and
similar material may be omitted. For the official text, visit the original source.
§ 870.2345
Electrocardiograph software for over-the-counter use.
Covers electrocardiograph software intended for over-the-counter use.
Covers electrocardiograph software intended for over-the-counter use.
(a) Identification.
An electrocardiograph software device for over-the-counter use creates, analyzes, and displays electrocardiograph data and can provide information for identifying cardiac arrhythmias. This device is not intended to provide a diagnosis.
Creates, analyzes, and displays electrocardiograph data to identify cardiac arrhythmias without diagnosing.
Creates, analyzes, and displays electrocardiograph data to identify cardiac arrhythmias without diagnosing.
(b) Classification.
Class II (special controls). The special controls for this device are:
(1) Clinical performance testing under anticipated conditions of use must demonstrate the following:
(i) The ability to obtain an electrocardiograph of sufficient quality for display and analysis; and
(ii) The performance characteristics of the detection algorithm as reported by sensitivity and either specificity or positive predictive value.
(2) Software verification, validation, and hazard analysis must be performed. Documentation must include a characterization of the technical specifications of the software, including the detection algorithm and its inputs and outputs.
(3) Non-clinical performance testing must validate detection algorithm performance using a previously adjudicated data set.
Specifies clinical and non-clinical testing, software analysis, and documentation requirements for Class II devices.
Specifies clinical and non-clinical testing, software analysis, and documentation requirements for Class II devices.
(4) Human factors and usability testing must demonstrate the following:
(i) The user can correctly use the device based solely on reading the device labeling; and
(ii) The user can correctly interpret the device output and understand when to seek medical care.
(5) Labeling must include:
(i) Hardware platform and operating system requirements;
(ii) Situations in which the device may not operate at an expected performance level;
(iii) A summary of the clinical performance testing conducted with the device;
(iv) A description of what the device measures and outputs to the user; and
(v) Guidance on interpretation of any results.
Requires usability testing to ensure correct device use and interpretation; mandates comprehensive device labeling information.
Requires usability testing to ensure correct device use and interpretation; mandates comprehensive device labeling information.